BVI Medical Announces CE Mark for Virtuoso Dual-Function Surgical Platform
BVI Medical, Inc. has received the CE Mark for its Virtuoso®, a dual-function phaco-vitrectomy surgical platform designed for cataract and vitreoretinal procedures. This certification allows for commercialization across European markets, enhancing surgical control and efficiency. The platform is currently undergoing clinical evaluation at LMU Klinikum in Germany and has demonstrated promising results in initial procedures. Commercial availability is expected in Q3 2026.
WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) — BVI, a global leader in ophthalmic device innovation, today announced that Virtuoso® has received the CE Mark under the European Union Medical Device Regulation (EU MDR), enabling commercialization across markets recognizing the CE Mark. Virtuoso® is BVI’s next-generation phaco-vitrectomy surgical platform, a dual-function system designed to support both cataract and vitreoretinal procedures on a single, integrated platform.